CURRICULUM VITAE
`Paul A. Godley, MD, PhD, MPP
`
`
`
`
`
`
`
`
`
`UNC School of Medicine
`4064 Bondurant Hall, CB #7000
`Chapel Hill, NC 27599-7000
`(919) 843-4773
`
`101 Songbird Lane
`Chapel Hill, NC 27514
`(919) 933-2898
`
`
`
`
`
`PERSONAL DATA
` Work Address:
`
`
`
`
`Home Address:
`
`
`
`
`
`CURRENT POSITION Vice Dean for Finance and Administration, UNC School of Medicine
`
`Rush Dickson Distinguished Professor of Medicine (Hematology/Oncology)
`and Urology
`
`Director, UNC Program on Ethnicity, Culture and Health Outcomes
`
`HARVARD MEDICAL SCHOOL Boston, MA
`
`YALE UNIVERSITY New Haven, Connecticut
`Magna cum laude, Departmental Honors in Sociology
`
`
`
`EDUCATION
`
`
`9/1987 – 5/1993 Ph.D. UNIVERSITY OF NORTH CAROLINA at Chapel Hill
`
`
`Epidemiology
`
`9/1982 – 6/1984 M.P.P. HARVARD UNIVERSITY J. F. Kennedy School of Government
`
`
`Master in Public Policy, Health Policy concentration
`
`9/1979 – 6/1984 M.D.
`
`
`9/1975 – 5/1979 B.A.
`
`
`
`POSTGRADUATE TRAINING
`
`7/1988 – 6/1991
`
`
`
`7/1987 – 6/1989
`
`
`
`7/1984 – 6/1987
`
`
`
` UNIVERSITY OF NORTH CAROLINA at CHAPEL HILL
`
`School of Medicine, Department of Medicine
`
`Fellow, Hematology/Oncology
`
` UNIVERSITY OF NORTH CAROLINA at CHAPEL HILL
`
`School of Public Health, Department of Epidemiology
` NRSA Research Fellow, Cancer Epidemiology Program
`
`
`
` CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE
` University Hospitals of Cleveland, Cleveland, OH
`
`Intern and Resident, Internal Medicine
`
`WCK1003
`Page 1
`
`

`
`LEADERSHIP APPOINTMENTS
`1/2015 – Present
` Vice Dean For Finance And Administration
`7/2011 – 1/2015
` Executive Associate Dean For Faculty Affairs, UNC School Of Medicine
`
`FACULTY APPOINTMENTS
`4/2016 – Present
` Rush Dickson Distinguished Professor of Prostate Cancer Research
`7/2014 – Present
` Professor, UNC Department of Urology
`7/2008 – Present
` Professor, UNC Division of Hematology/Oncology
`11/2008 – Present
` Adjunct Professor, UNC Department of Epidemiology
`1/2001 – 10/2008
` Adjunct Associate Professor, UNC Department of Epidemiology
`7/2000 – 6/2008
` Associate Professor UNC Division of Hematology/Oncology
`11/1994 – 12/2000 Clinical Assistant Professor, Department of Epidemiology
`7/1992 – 2000
` Assistant Professor, UNC Division of Medical Oncology
`7/1991 – 6/1992
` Instructor, UNC Division of Medical Oncology
`7/1990 – 6/1991
` Research Instructor, UNC Division of Medical Oncology
`
`RESEARCH INTERESTS
`Cancer Health Disparities
`Health Services Research focusing on cancer
`Prostate cancer screening and chemoprevention
`
`GRANT SUPPORT
`
`Current:
`Carolina Community Network Center to Reduce Cancer Health Disparities (CCN II) 1-U54-CA153602-01,
`NCI, Principal Investigator. 09/01/10-08/31/16 (Total Direct Cost $3,044,187).
`
`North Carolina Translational & Clinical Sciences Institute (NC TRACS) 5UL1TR001111-02 NIH (Runge)
`Investigator 09/26/13 - 04/30/18. $11,497,887 (Total Direct Cost $58,856,039)
`
`PROMIS Validation in Prospective Population-based Prostate Cancer Research Study. (Chen) 1 R01
`CA174453-01. NCI. Investigator 09/21/12-07/31/16. (Total Direct Cost $900,000)
`
`Past:
`The Investigation of the Role of Dietary Lipids in the Etiology of Prostate Cancer. National Cancer Institute
`Cancer Center Support Grant (CA16086), Minority Cancer Control Supplement #: 3 P30 CA16086-14S1
`Project 4, 8/89-7/91. Principal Investigator. $46,000.
`
`Recruiting Minority Patients into Cancer Treatment Protocols. Cancer and Leukemia Group B. 9/90-8/91.
`Principal Investigator. $23,500.00
`
`The Impact of the Minority Based Community Clinical Oncology Program on the Diffusion of Optimal Med-
`ical Practices. Lineberger Comprehensive Cancer Center. 1/91-12/92. Principal Investigator. $2,500.
`
`Race, Fatty Acids, and Prostate Cancer Risk. National Cancer Institute 1 R01 CA55760-01 10/91 - 9/96.
`Principal Investigator. $1,027,225.00
`
`Uncertainty Management of Stage B Prostate Cancer”; Co-Investigator: Paul Godley, National Cancer Insti-
`tute, 09/30/93-08/31/97, $460,050.
`
`WCK1003
`Page 2
`
`

`
`Phase I Single and Multiple Dose Safety and Pharmacokinetic Efficacy Clinical Study of Genistein in Prostate
`Neoplasia; Co-Investigator: Paul Godley, National Cancer Institute, 09/30/96-11/30/97, $798,187.
`
`Pilot Study of Prostate Cancer Gene Discovery - Cancer Genetics Network; National Cancer Institute
`09/01/99 – 08/31/00, Principal Investigator. $70,000, total cost.
`
`Tissue Vitamin E Levels and Prostate Cancer Risk. National Cancer Institute (5-R03-CA81613) 04/01/99 -
`3/31/01. $99,509.
`
`Prostate Cancer Screening Efficacy in African Americans using Case-Control Methodology. U.S. Army medi-
`cal Research and Materiel Command MP980008. 1/1/99-06/30/01. Principal Investigator. $49,470.00
`
`Institute of Nutrition, University of North Carolina. Grant #: 410. 7/90-6/91. Principal Investigator. $9,980.
`
`Racial differences in prostate cancer treatment outcomes. ATPM/CDC (TS323-15/15) 09/30/99 –
`09/29/01. Principal Investigator $258,043
`
`A Case Control Study of Prostate Cancer Screening; American Cancer Society (CCE-88984), 05/01/99-
`04/30/02, Principal Investigator $867,000, total cost.
`
`Racial differences in prostate cancer treatment outcomes (TS323-15/15), ATPM/CDC, 09/30/99 –
`09/29/02, Principal Investigator. $189,043
`
`American Cancer Society Clinical Oncology Career Development Award 1990-1992. Grant #: 90-205.
`$90,000.
`
`Dietary Essential Fatty Acids and Prostate Cancer Risk; PI: Paul Godley, National Cancer Institute,
`07/01/98-06/30/03, $3,286,031, total cost.
`
`Cancer Genetic Network – UNC Components. National Cancer Institute (1-U24-CA78157-01) 08/01/98 –
`7/31/03. Subcontract PI $106,649
`
`PSA Screening, Race and Prostate Cancer Treatment Choice. CDC (U48/CCU409660) 09/30/00 –
`09/29/03. Principal Investigator. $208,265
`
`Center of Excellence on Overcoming Racial Health Disparities (4946-P) The Duke Endowment, 01/01/00 –
`12/31/03, Co-Investigator $300,00
`
`
`African American Faith-Based Coalition Against Cancer. National Institute of Health. (1 U01-CA86116-03)
`03/01/00 – 02/28/05. Principal Investigator. $2,550,027
`
`Understanding and Eliminating Minority Health Disparities, Agency for Healthcare Research & Quality (P01
`HS10861), Co-Investigator, 09/01/00 – 08/31/06. $998,303
`
`
`
`Racial Differences in Prostate Cancer Screening and Care Seeking Behaviors: Influence of Health Care Inter-
`action and Host and Tumor Biology, Department of Defense, (DAMD17-03-2-0052), Co-Investigator,
`09/01/03-08/31/06. $421,465
`
`
`
`WCK1003
`Page 3
`
`

`
`A Case Control Study of Prostate Cancer Screening among African American and Caucasian Medicare Recip-
`ients, DOD (PC040795), Principal Investigator, 09/15/04-09/14/06. $485,883
`
`The SUMMER Center is devoted to developing new minority investigators to conduct health services re-
`search pertaining to minority elderly, focusing on the utilization of health services and long-term care of ur-
`ban and rural elders, particularly in the South, Agency for Healthcare Research (5-R24 HS013353-02),
`01/01/03-11/30/06, Co-Investigator. $107,238
`
`UNC-Chapel Hill/Shaw University: Partnership for Health Disparity Research. (1-P-60-MD000244-01)
`09/30/2002 – 08/31/2007. Principal Investigator, Direct $2,552,032.
`
`The UNC Program on Ethnicity, Culture and Health Outcomes (ECHO) (Glaxo Smith/Kline), North Caro-
`lina Foundation, 11/01/02 – 12/05/07, Director. $1,400,000
`
`The Shaw UNC-CH Center for Prostate Cancer Research (SUCPCR), DOD (W81ZWH0510208), 07/01/05
`- 06/30/08, Co-Investigator. $164,250
`
`Carolina Community Network to Reduce Cancer Health Disparities (1 U01 CA114629-01), NCI, 04/01/05 -
`03/31/10, Principal Investigator. (Total Direct Cost $2,911,863)
`
`Disparities in the Diffusion of the State-of-Art Prostate Cancer Treatments (PC060911), 12/01/06 –
`2/11/09, Department of Defense, Principal Investigator, (Total Direct Cost $300,000)
`
`Shaw University-University of North Carolina at Chapel Hill Undergraduate Program in Prostate Cancer Re-
`search and Training (SUUPPRT) (PC061634), 01/01/07 – 12/31/10, Department of Defense, Principal In-
`vestigator, (Total Direct Cost $165,370)
`
`Paul Calabresi Award For Clinical Oncology(K12) 1K12CA120780 NIH/NCI (Goldberg) Program Director,
`09/17/07 – 08/31/12. $191,834. (Total Direct Cost $1,862,516).
`
`Implementing Systemic Interventions to Close the Discovery Delivery Gap 1R01CA1244021A1 NIH Co-
`Principal Investigator 08/15/07 - 05/31/12. $ 335,834 (Total Direct Coast 2,322,392)
`
`NC STRONG Center for Healthy Survivorships: Lineberger Lance Armstrong Center of Excellence and
`Community Partnerships, Lance Armstrong Foundation, (Campbell) Co-Principal Investigator, 01/01/08 –
`12/31/12. $377,273 (Total Direct Cost $1,453,093)
`
`UNC-CH/SHAW: Partnership for Health Disparities Research 2 P60 MD000244-06 07/01/07 – 5/31/13
`National Center on Minority Health Health Disparities, Principal Investigator. $1,395,028 (Total Direct Cost
`$5,512,464).
`
`Comparative Effectiveness of Management Options for Localized Prostate Cancer. HHSA290-2005-0040-I-
`TO6. Agency for Healthcare Research and Quality (AHRQ) Principal Investigator. 07/15/10-07/14/13 (To-
`tal Direct Cost $$2,282,610)
`
`WCK1003
`Page 4
`
`

`
`RESEARCH TRAINEES
`
`Mentor
`Trainees
`Christine
`Chung
`(post)
`
`Training
`Period
`
`Degree
`Earned
`
`Prior
`Degree Award
`Date
`
`Award-
`ing Institution
`
` Research Project Title
`
` Current Position
`
`2000-
`2002
`
`NA
`
`MD
`
`1998 Eastern
`Virginia
`University
`
`Genomics of Head &
`Neck Cancers
`
`Tumor Suppressor
`Proteins in Lung Can-
`cers
`
`David Reisman 2001-
`
`2003
`(post)
`
`NA
`
`Catherine
`Hoyo
`(post)
`
`2001-
`2003
`
`NA
`
`MD, PhD 1995 Univ of
`Texas
`Medical
`Branch, TX
`1998 UNC-
`Chapel Hill
`
`PhD
`
`William Car-
`penter (post)
`
`2004-
`2007
`
`NA
`
`PhD
`
`Wobker,
`Sara (post)
`
`2008-
`2010
`
`NA
`
`MD MPH 2008 UNC-
`Chapel Hill
`
`Associate
`Professor of
`Oncology, Johns
`Hopkins Univ
`Associate
`Professor,
`University of
`Florida
`
`Associate
`Professor, NC
`State University
`
`Improving participa-
`tion of African-
`American men in re-
`search studies.
`Associate
`
`2004 UNC Chapel Diffusion of state-of-
`Professor, UNC
`Hill
`the-art cancer treat-
`Chapel Hill
`ment
`Pathology
`Systematic Review Of
`Residency, UNC
`The Literature Re-
`School of
`garding HRQOL After
`Medicine
`Primary Treatment
`For Localized Pros-
`tate Cancer
`Racial differences in
`access to services,
`health beliefs, screen-
`ing behavior, &
`health-related quality
`of life in nc men w/
`early prostate cancer
`Attending
`Racial differences in
`Urologist, Univ
`prostate cancer
`of Toronto
`treatment side-effects
`Associate Prof,
`Public policy and eth-
`1998 Harvard
`Duke University
`ics of clinical cancer
`Medical
`Medical Center
`research
`School
`Assistant
`Longitudinal epidemi-
`2008 UNC Chapel
`ology of pain among
`Professor of
`Hill
`
`patients with breast or Medicine,
`prostate cancers
`Vanderbilt
`University
`Medical Center
`
`2005 Virginia
`Common-
`wealth Univ
`
`Research Health
`Analyst at RTI
`International
`
`2003 Univ of To-
`ronto
`
`Pamela
`Spain (post)
`
`2005-
`2007
`
`NA
`
`PhD
`
`Rob
`2005-
`2006
`Hamilton (post)
`
`NA
`
`MD
`
`Jeffrey Pep-
`percorn (post)
`
`2005-
`2008
`
`NA
`
`MD
`
`Liana
`Castel (post)
`
`2005-
`2008
`
`NA
`
`PhD
`
`WCK1003
`Page 5
`
`

`
`Whitney Rob-
`inson (pre)
`
`2002-
`2006
`
`PhD BS
`
`Do, Young
`Kyung (post)
`
`2006-
`2007
`
`N/A
`
`DO
`
`2001 Harvard
`University
`
`1997 Seoul Na-
`tional Univ
`College of
`Medicine
`
`Song, Lixin
`(post)
`
`2011 -
`Present
`
`NA
`
`PhD
`
`2009 Univ of
`Michigan
`
`Kuykendal,
`Adam (post)
`
`2011 -
`Present
`
`NA
`
`MD
`
`2007 University of
`North
`Carolina
`School of
`Medicine
`
`Holmes, Jordan
`(pre)
`
`2010 -
`Present
`
`MD
`
`BS
`
`2007 NC State
`University
`
`Risk of Prostate Can-
`cer and body fat
`composition
`Carolina Prostate
`Cancer Treatment
`Outcomes
`
`Assistant
`Professor, UNC
`Chapel Hill
`Assistant
`Professor,
`Duke-NUS
`Graduate
`Medical School,
`Singapore
`Assistant
`How Does Medical
`Professor, UNC
`Literacy Affect Quality
`of Life among Men
`Chapel Hill
`
`with Newly Diagnosed School of
`Clinically Localized
`Nursing
`Prostate Cancer? --
`Findings from PCaP
`Study
`Utilization of Andro-
`gen Deprivation in
`Localized Prostate
`Cancer Patients.
`
`NRSA Health
`Services Re-
`search Postdoc-
`toral Fellow
`(NIH/AHRQ T-
`32 HS000032-
`19), Sheps Cen-
`ter for Health
`Services Re-
`search, UNC
`UNC Radiation
`Oncology
`Resident
`
`Is Primary Prostate
`Cancer Treatment
`Influenced by Likeli-
`hood of Extraprostatic
`Disease? A Patterns
`of Care Study Using
`SEER
`
`WCK1003
`Page 6
`
`

`
`Nielsen,
`Matthew (post)
`
`2009 –
`present
`
`NA
`
`MD
`
`2002
`
` Johns
`Hopkins
`University
`
`Risk-Appropriate
`Treatment as a Metric
`of Quality Cancer
`
`Chen, Ronald
`(post)
`
`2009 –
`present
`
`NA
`
`MD
`
`2004
`
`Wang, Andrew
`Z. (post)
`
`2009 -
`present
`
`NA
`
`MD
`
`2004
`
`Harvard
`Medical
`School
`
`Harvard
`Medical
`School
`
`Racial Differences in
`prostate cancer
`treatment outcomes
`after adjustment for
`pretreatment progno-
`sis
`Particle-loaded spac-
`ers for prostate can-
`cer brachytherapy
`
`Cobran,Ewan K.
`(post)
`
`2012-
`present
`
`NA
`
`PhD
`
`2012
`
`Howard
`University
`
`Perceptions of pros-
`tate cancer fatalism
`and screening behav-
`ior between US-born
`and Caribbean-born
`black males
`
`Assistant
`Professor, UNC
`School of
`Medicine, Dept
`Urology
`
`Associate
`Professor, UNC
`School of
`Medicine, Dept
`of Radiation
`Oncology
`Assistant
`Professor, UNC
`School of
`Medicine, Dept
`of Radiation
`Oncology
`Assistant
`Professor Univ
`of Georgia
`College of
`Pharmacy
`
`
`
`CERTIFICATION AND LICENSURE
`
`Specialty Certification:
`AMERICAN BOARD OF INTERNAL MEDICINE
`Diplomate, Internal Medicine, Sept. 16, 1988.
`Board Certified, Medical Oncology, 1991, 2002, 2014
`
`Licensure:
`North Carolina License #31290 June 13, 1987
`
`EXECUTIVE EDUCATION
`
`AAMC Executive Diversity Leadership Certificate June, 2014
`AAMC Executive Development Seminar for Interim and Aspiring Leaders. May, 2013
`Faculty Learning Community on Strategy and Leadership, UNC Center for Faculty Excellence. 2011 - 2012
`Grinnell Leadership, Leadership Jumpstart. December 2007
`
`HONORS AND AWARDS
`
`Magna cum laude - 1979
`Departmental Honors in Sociology - 1979
`America’s Top Doctors - Medical Oncology - 2010 - 2014
`AOA Honor Medical Society. Faculty Inductee 2013
`
`
`WCK1003
`Page 7
`
`

`
`COMMITTEE AND ADMINISTRATIVE SERVICE
`
`National and International:
`2014–Present
` Co-Chair NCORP Cancer Care Delivery Research Steering Committee, NCI
`2002– 2011
` Advisory Committee, Office of Medical Applications of Research, NIH
`2000–Present
` Associate Editor, Journal of the National Cancer Institute
`2008 – 2011
` Chair, Data Monitoring Committee, Ferring Pharmaceuticals
`2006 – 2011
` Chair, Independent Data Monitoring Committee, GlaxoSmithKline, REDEEM Trial
`2002
` Panel Member, NIH State–of–the–Science Concensus Conference. Management of
`the Clinically Inapparent Adrenal Mass (Incidentaloma)
` Chair, Data and Safety Monitoring Committee, SELECT Prostate Cancer Prevention
`Trial NCI/Southwest Oncology Group
` Chair, Data and Safety Monitoring Committee Prostate Cancer Prevention Trial
`(PCPT), Southwest Oncology Group/National Cancer Institute
`
`2000 – 2008
`
`1996 – 2003
`
`2003 – Present
`
`2001 – Present
`2008 – 2010
`2000 – 2003
`
`
`University and Medical School:
`2005 – 2013
` UNC KL2 Program Advisory committee
`2004 – Present
` The North Carolina Advisory Committee on Cancer Coordination and Control. Gu-
`bernatorial appointment
` Director, Health Disparities Program and Senior Fellow, UNC Sheps Center for
`Health Services Research
` Director, UNC Program on Ethnicity, Culture, and Health Outcomes
` UNC School of Medicine, Part-Time Tenure Review Committee
` Chair, Data and Safety Monitoring Committee, University of North Carolina School
`of Medicine.
` Admissions Committee, UNC School of Medicine
`
`1999–2002
`
`Department and Cancer Center:
`2012 – Present
` Chair, Data and Safety Monitoring Committee, UNC Lineberger Comprehensive
`Cancer Center
` Hematology/Oncology Executive Committee, UNC School of Medicine
` Fellows Education Committee Member, Hematology/Oncology Fellowship Training
`Program, University of North Carolina School of Medicine
` Program Director, Combined Hematology/Oncology Fellowship Training Program,
`University of North Carolina, School of Medicine
` Training Advisory Committee, Cancer Control Education Program, UNC Lineberger
`Comprehensive Cancer Center
`
`2004 – 2010
`1999 – 2010
`
`1999 – 2005
`
`1997 – Present
`
`WCK1003
`Page 8
`
`

`
`FUNDING/REVIEW GROUPS
`
`2015 – Present
`2009
`2007
`2002
`
` Co-Chair, NCI Cancer Control Delivery Research Steering Committee
` Chair, NCI-DCP Community Clinical Oncology Program External Review
` National Community Cancer Centers Program review committee, NCI.
` Chair, Special Emphasis Panel, NIH PEER Review Committee, Community Clinical
`Oncology Program
` Chair, American Cancer Society Study Section, Clinical Research, Cancer Control
`and Epidemiology
` Chair, Special Emphasis Panel, NIH Peer Review Committee, Community Clinical
`Oncology Program
` Member, American Cancer Society Study Section, Clinical Research, Cancer Con-
`trol and Epidemiology. (Chair 6/02 – 6/03)
` Chair, Special Emphasis Panel, NIH Peer Review Committee.
` Chair, National Cancer Institute Special Emphasis Panel, Minority CCOP Program,
`Peer Review Committee, NCI.
` Scientist Reviewer, USAMRMC Prostate Cancer Research Program,
` Special Emphasis Panel, NIH Peer Review Committee, Community Clinical Oncol-
`ogy Program
` Chair, Genetic Epidemiology Poster Session, American Association for Cancer Re-
`search Annual Meeting
` USAMRMC Prostate Cancer Research Program Panel: Epidemiology, Behavioral &
`Social Sciences and Health Care Delivery
` Special Review Committee Meeting. Review–RFP Recruitment Centers for African
`American Hereditary Prostate Cancer Network, NCI
` Special Emphasis Panel Meeting, Prostate, Lung, Colorectal and Ovarian (PLCO)
`Cancer Screening Trial Expansion for Minority Enrollment
` National Cancer Institute Prostate Cancer Progress Review Group
` American Cancer Society Prostate Cancer Data Review Workshop (prostate cancer
`screening guidelines)
` National Medical Association Mammography Workshop on breast cancer screening
`guidelines (40-50 years of age)
` Special Emphasis Panel, NIH Peer Review Committee, Community Clinical Oncol-
`ogy Program
` Special Review Committee Site Visit, Karmanos Cancer Institute, Wayne State Uni-
`versity, Cancer Centers Branch. NCI, Detroit, MI
` Special Emphasis Panel, NIH Peer Review Committee, Community Clinical Oncol-
`ogy Program
`
`2002 – 2003
`
`2001
`
`2000–2002
`
`2000
`2000
`
`1999
`1998
`
`1998
`
`1998
`
`1997
`
`1997
`
`1997
`1997
`
`1997
`
`1996
`
`1996
`
`1995
`
`WCK1003
`Page 9
`
`

`
`1995
`
`1995
`
`1994
`
`1994
`
`1993
`
`1992
`
`1991
`
`
`
` Special Review Committee Meeting, Development Grants for New Research Pro-
`grams in Prostate Cancer, NCI
` Special Review Committee Site Visit, USC/Norris Cancer Center, Cancer Centers
`Branch. National Cancer Institute, Los Angeles, CA
` Special Emphasis Panel, NIH Peer Review Committee, Community Clinical Oncol-
`ogy Program
` Special Review Committee Meeting, CARET - The Carotene and Retinol Efficacy
`Trial. National Cancer Institute
` Special Emphasis Panel, NIH Peer Review Committee, Community Clinical Oncol-
`ogy Program
` Special Emphasis Panel, NIH Peer Review Committee, Community Clinical Oncol-
`ogy Program
` Special Emphasis Panel, NIH Peer Review Committee, Community Clinical Oncol-
`ogy Program
`
`TEACHING ACTIVITIES
`
`Clinical Epidemiology and Preventive Medicine, Seminar Leader
`Department of Social Medicine, 1988, 1990, 1993, 1995, 1996
`
`Hematology/Oncology Pathophysiology Course, Lecturer
`Department of Medicine, 1991–2001
`
`Cancer Prevention and Control, Lecturer
`HPAA 308, EPID 140, HBHE 204, 1993–2000
`
`EXTRAMURAL INVITED PRESENTATIONS
`
`American Society of Clinical Oncology Educational Lecture
`Chicago, IL
`June 1, 2013
`"High-Risk Populations and Cancer Screening: Prostate Cancer"
`
`Third Society for Translational Oncology Annual Meeting
`October 21, 2012
`Chapel Hill, NC
`"PSA Screening for Prostate Cancer: Current Status, Future Directions"
`
`24th Annual Fall Foliage Cancer Conference
`October 20, 2012
`Asheville, NC
`"Prostate Cancer Screening: Current Status & Emerging Screening Tests"
`
`WCK1003
`Page 10
`
`

`
`NCI Invited Talk
`Bethesda, MD
`February 16, 2011
`"Efficacy of PSA Screening for Prostate Cancer Among Elderly African Americans: A Case-Control Study"
`
`Patient and Professional Education Symposium on Prostate Cancer
`Jacksonville, FL
`July 17, 2010
`
`Dare County Cancer Clinic
`July 10, 2009
`Treatment of Prostate Cancer
`
`Wake AHEC Symposium
`August 27, 2008
`Prostate Cancer Screening
`
`Spring Meeting, Southwest Oncology Group
`Chicago, IL
`May 2, 2007
`“Role of Data and Safety Monitoring Committees”
`
`2nd Annual Texas Conference on Health Disparities
`UNT Health Science Center
`Fort Worth, TX
`June 1, 2007
`“Prostate Cancer Screening”
`
`Halifax Medical Center
`Daytona Beach, FL
`March 28, 2007
`“New Therapies for Renal Cell Carcinoma”
`
`PSA Effectiveness
`UNC School of Nursing, Carrington Hall
`October 17, 2006
`
`Keynote Speaker, Prostate Cancer Racial Disparities
`Tuskegee University
`July 24, 2006
`
`Overview of Health Disparities. Promoting and Cultivating Health Disparities Research.
`North Carolina Central University
`Durham, NC, June 12, 2006
`
`Prostate Cancer Update
`Internal Medicine Grand Rounds, Coastal AHEC
`Wilmington, NC, July 28, 2006
`
`WCK1003
`Page 11
`
`

`
`Racial Differences in Prostate Cancer Outcomes.
`Morehouse School of Medicine/Tuskegee University/UAB CCC
`Partnership Summer Institute,
` July 24, 2006
`
`Overview of Health Disparities Research
`Health and Wellness Trust Fund, Research Triangle Park, NC
`September 18, 2006
`
`Research Careers
`Shaw University's First Annual Conference on Minority Health Disparities
`September 8, 2006. Raleigh, NC
`
`Racial Health Disparities
`Preventive Medicine Residency Seminar Series
`May 11, 2005
`
`Prostate Cancer Epidemiology
`Internal Medicine Grand Rounds, Coastal AHEC
`Wilmington, NC, August 24, 2005
`
`Moving From Observational Studies to Clinical Trials: Why Do We Sometimes Get It Wrong?
`Distinguishing Causal from Noncausal Associations, Rapporteur.
`The National Institutes of Health, January 11–12, 2005.
`
`“Update of Prostate Cancer”
`North Carolina Oncology Association's Fall Meeting
`Pinehurst, NC
`August 21, 2004
`
`Prostate Cancer
`National Institute of Environmental Health Sciences
`February 2004.
`
`Hematology/Oncology Grand Rounds
`Strong Memorial Hospital
`January 2004.
`
`Race & Prostate Cancer Risks
`Multidisciplinary Advances in the Treatment of Genitourinary Cancers
`Friday Center
`February 13, 2004
`
`Annual Biomedical Research Conference for Minority Students
`Hyatt Regency Hotel
`Dallas, TX, November 2004
`
`WCK1003
`Page 12
`
`

`
`Treatment of Prostate Cancer
`Internal Medicine Update
`Chapel Hill, NC. April 2, 2004.
`
`Mountain area health education center Teleconference
`“Prostate cancer update”
`November16, 1999
`
`“Cancer in the Black Community and Clinical Trials” Community and Science: Models for Success.
`Tuskegee University. Tuskegee, AL
`11/19/98.
`
`“Prostate Cancer Prevention.”
`Medical Grand Rounds, Wake Medical Canter
`Raleigh, NC. July 14, 1998.
`
`“Epidemiology of Prostate Cancer.”
`Internal Medicine Update
`Chapel Hill, NC. April 2, 1998.
`
`“Nutritional and Environmental Risk Factors for Prostate Cancer.”
`Leadership Conference on Prostate Cancer in the African American Community
`ACS, CDC, NCI. November 20, 1997,
`
`“Call to Action: Increasing Minority Involvement in Cancer Clinical Trials.”
`Comprehensive Cancer Center of Wake Forest University.
`Winston-Salem, NC. July 24,1997.
`
`Co-Chair Prostate Cancer Roundtable. State of North Carolina
`DEHNR, Division of Health Promotion.
`Research Triangle Park, NC. May 16,1997.
`
`“Update on Prostate cancer Research.”
`16 Institutions Health Sciences Consortium 24th Annual Symposium
`Greensboro, NC. February 27, 1997.
`
`“The Role of Fatty Acids in Prostate Cancer Risk.”
`Hematology/Oncology Grand Rounds, Bowman Gray School of Medicine
`Winston-Salem, NC May 2, 1997
`
`The Pros and Cons of Prostate Cancer Screening.
`19th Annual Minority health Conference
`Chapel Hill, NC February 14, 1997.
`
`Update on Prostate Cancer Screening.
`Medical Grand Rounds, New Hanover Regional Medical Center
`Wilmington, NC August 23, 1995.
`
`WCK1003
`Page 13
`
`

`
`Prostate Cancer in African Americans
`Old North State Medical Society, Annual Convention.
`Myrtle Beach, SC. June 23, 1995.
`
`Update on Prostate Cancer Early Detection.
`Medical Grand Rounds. Wake Medical Center,
`Raleigh, NC. 1994.
`
`Interferons in Oncology.
`AHEC Presentation.
`Laurinberg, NC. 1994.
`
`Screening for Prostate Cancer
`Controversies in the Epidemiology of Prostate Cancer.
`National Medical Association Annual Convention. Orlando, FL July 27,1994
`
`Specific Nutrients and Chemoprevention
`Section Chair. 20th Annual Public Health Nutrition Update Conference:
`Antioxidant Nutrients and Cancer. UNC-CH School of Public Health.
`Chapel Hill, NC. April 21, 1994.
`
`The Role of Lipids in the Etiology of Prostate Cancer.
`Emory University School of Public Health, Division of Epidemiology.
`Atlanta, GA, March 23, 1994.
`
`Screening for Prostate Cancer: Is it Time to Say No?
`Hematology/Oncology Grand Rounds, Emory University School of Medicine.
`Atlanta, GA, March 23, 1994.
`
`Screening for Prostate Cancer
`Grand Rounds, Duke University Medical Center.
`Durham, NC July 23, 1993.
`
`Erythrocyte Membrane Fatty Acid Composition and Prostate Cancer Risk.
`Presented at the 26th Annual Meeting of the Society for Epidemiologic Research.
`Keystone, Colorado, June 18, 1993.
`
`Screening for Prostate Cancer. Grand Rounds
`Moses Cone Medical Center.
`Greensboro, NC June 11, 1993.
`
`Adipose Tissue Fatty Acid Composition and Risk of Prostate Cancer.
`Presentation at the 17th Annual Meeting of the American Society of Preventive Oncology.
`Tucson, Arizona, March 21, 1993.
`
`Controversies in Prostate Cancer, Moderator.
`Mini-symposium at the 17th Annual Internal Medicine Conference.
`Chapel Hill, NC March 18, 1993
`
`WCK1003
`Page 14
`
`

`
`The Neurologic Complications of Cancer.
`Franklin Regional Medical Center,
`Louisburg, NC October 8, 1991.
`
`The Myth of the Male PAP Test.
`Medical Grand Rounds. UNC Hospitals,
`Chapel Hill, NC. December 19, 1991.
`
`Prostate Cancer Research.
`Lineberger Comprehensive Cancer Center Board of Visitors meeting
`William and Ida Friday Continuing Education Center
`Chapel Hill. NC, November 22, 1991.
`
`Epidemiology of Prostate Cancer.
`Third Annual Clinical Cancer Conference.
`William and Ida Friday Continuing Education Center
`Chapel Hill, NC. November 15, 1991.
`
`Screening for Prostate Cancer.
`Medical Grand Rounds. Wake Medical Center
`Raleigh, NC. September 24, 1991.
`
`The Role of Omega-3 Fatty Acids in the Etiology of Prostate Cancer.
`UNC Institute of Nutrition, First Annual Research Symposium.
`Raleigh, NC. March 22, 1991.
`
`The Role of Lipids in the Etiology of Prostate Cancer.
`Innovative Approaches to Minority Health Issues. UNC School of Public Health
`Chapel Hill, NC. February 14, 1991.
`
`The Early Diagnosis and Prevention of Prostate Cancer.
`Cancer Prevention Task Force, Lineberger Comprehensive Cancer Center
`Chapel Hill, NC. December 11, 1990.
`
`The Role of Lipids in the Etiology of Prostate Cancer.
`Triangle Cancer Epidemiologists (TRICEP). Lineberger Comprehensive Cancer Center
`Chapel Hill, NC. November 12,1990.
`
`The Role of Lipids in the Etiology of Prostate Cancer
`Cancer Centers Minority Enhancement Award Program Workshop
`AMC Cancer Research Center, Denver, CO. September 24, 1990.
`
`The Role of Omega-3 Fatty Acids in the Etiology of Prostate Cancer.
`Presentation at a Workshop at the 22nd Annual Meeting of the Society for Epidemiologic Research. (SER)
`Birmingham, AL. June 12, 1989.
`
`
`WCK1003
`Page 15
`
`

`
`BIBLIOGRAPHY
`
`Peer-reviewed publications:
`
`1.
`
`2.
`
`3.
`
`4.
`
`5.
`
`6.
`
`7.
`
`8.
`
`9.
`
`Rose TL, Deal AM, Basch E, Godley PA, Rathmell WK, Kim WY, Whang YE, Dunn MW, Wang A,
`Chen RC, Nielsen ME, Pruthi RS, Wallen EM, Woods ME, Smith AB, Milowsky MI. Neoadjuvant
`chemotherapy administration and time to cystectomy for muscle-invasive bladder cancer: An evalua-
`tion of transitions between academic and community settings. Urol Oncol. 2015 Sep;33(9):386.e1-6.
`
`Trantham LC, Carpenter WR, DiMartino LD, White B, Green M, Teal R, Corbie-Smith G, Godley
`PA. Perceptions of cancer clinical research among African American men in North Carolina. J Natl
`Med Assoc. 2015 Feb;107(1):33-41. PubMed PMID: 26113749; PubMed Central PMCID:
`PMC4477827.
`
`Cobran EK, Chen RC, Overman R, Meyer AM, Kuo TM, O'Brien J, Sturmer T, Sheets NC, Goldin
`GH, Penn DC, Godley PA, Carpenter WR. Racial Differences in Diffusion of Intensity-Modulated
`Radiation Therapy for Localized Prostate Cancer. Am J Mens Health. 2015 Feb 5. pii:
`1557988314568184. [Epub ahead of print] PubMed PMID: 25657192.
`
`Chen RC, Carpenter WR, Kim M, Hendrix LH, Agans RP, Meyer AM, Hoffmeyer A, Reeve BB,
`Nielsen ME, Usinger DS, Strigo TS, Jackman AM, Anderson M, Godley PA. Design of the North
`Carolina Prostate Cancer Comparative Effectiveness and Survivorship Study (NC ProCESS). J Comp
`Eff Res. 2015 Jan;4(1):3-9. doi: 10.2217/cer.14.67. PubMed PMID: 25565065.
`
`Song L, Weaver MA, Chen RC, Bensen JT, Fontham E, Mohler JL, Mishel M, Godley PA, Sleath B.
`Associations between patient-provider communication and socio-cultural factors in prostate cancer
`patients: a cross-sectional evaluation of racial differences. Patient Educ Couns. 2014 Dec;97(3):339-
`46. doi: 10.1016/j.pec.2014.08.019. Epub 2014 Sep 4. PubMed PMID: 25224313; PubMed Central
`PMCID: PMC4252656.
`
`Haynes-Maslow L, Godley P, Dimartino L, White B, Odom J, Richmond A, Carpenter W. African
`American women's perceptions of cancer clinical trials. Cancer Med. 2014 Oct;3(5):1430-9. doi:
`10.1002/cam4.284. Epub 2014 Jun 6. PubMed PMID: 24905181; PubMed Central PMCID:
`PMC4302693.
`
`Penn DC, Stitzenberg KB, Cobran EK, Godley PA. Provider-based research networks demonstrate
`greater hospice use for minority patients with lung cancer. J Oncol Pract. 2014 Jul;10(4):e182-90. doi:
`10.1200/JOP.2013.001268. Epub 2014 Apr 29. PubMed PMID: 24781367; PubMed Central PMCID:
`PMC4094645.
`
`Chen RC, Carpenter WR, Hendrix LH, Bainbridge J, Wang AZ, Nielsen ME, Godley PA. Receipt of
`guideline-concordant treatment in elderly prostate cancer patients. Int J Radiat Oncol Biol Phys. 2014
`Feb 1;88(2):332-8. doi: 10.1016/j.ijrobp.2013.11.004. PubMed PMID: 24411605.
`
`Thompson IM Jr, Goodman PJ, Tangen CM, Parnes HL, Minasian LM, Godley PA, Lucia MS, Ford
`LG. Long-term survival of participants in the prostate cancer prevention trial. N Engl J Med. 2013
`Aug 15;369(7):603-10. doi: 10.1056/NEJMoa1215932. PubMed PMID: 23944298; PubMed Central
`PMCID: PMC4141537.
`
`WCK1003
`Page 16
`
`

`
`10. Moore AD, Hamilton JB, Knafl GJ, Godley PA, Carpenter WR, Bensen JT, Mohler JL, Mishel M.
`The influence of mistrust, racism, religious participation, and access to care on patient satisfaction for
`African American men: the North Carolina-Louisiana Prostate Cancer Project. Journal of the National
`Medical Association. 2013;105(1):59-68.
`
`
`11.
`
`12.
`
`13.
`
`14.
`
`15.
`
`16.
`
`17.
`
`Stokes WA, Hendrix LH, Royce TJ, Allen IM, Godley PA, Wang AZ, Chen RC. Racial differences in
`time from prostate cancer diagnosis to treatment initiation: a population-based study. Cancer.
`2013;119(13):2486-93.
`
`Goldin GH, Sheets NC, Meyer AM, Kuo TM, Wu Y, Sturmer T, Godley PA, Carpenter WR, Chen
`RC. Comparative effectiveness of intensity-modulated radiotherapy and conventional conformal radi-
`otherapy in the treatment of prostate cancer after radical prostatectomy. JAMA Intern Med.
`2013;173(12):1136-43.
`
`Cobran EK, Wutoh AK, Lee E, Odedina FT, Ragin C, Aiken W, Godley PA: Perceptions of Prostate
`Cancer Fatalism and Screening Behavior Between United States-Born and Caribbean-Born Black
`Males. J Immigr Minor Health, 2014;16(3):394-400.
`
`Ellis SD, Blackard B, Carpenter WR, Mishel M, Chen RC, Godley PA, Mohler JL, Bensen JT: Receipt
`of National Comprehensive Cancer Network guideline-concordant prostate cancer care among Afri-
`can American and Caucasian American men in North Carolina. Cancer, 2013;119(12):2282-90.
`
`Odulana AA, Kim MM, Isler MR, Green MA, Taylor YJ, Howard DL, Godley PA, Corbie-Smith G:
`E